Depression rarely has a single cause. It typically emerges from a combination of biological vulnerabilities, life experiences, and ongoing stressors that interact in ways unique to each person. Some people develop depression after a clear trigger like a job loss or the death of a loved one. Others become depressed with no obvious external reason, driven by shifts in brain chemistry, genetics, or chronic inflammation they may not even be aware of. Understanding these overlapping factors helps explain why depression can feel so unpredictable and why it affects such a wide range of people.
Genetics Set the Stage
Depression runs in families, though not in a simple, predictable way. Twin studies have consistently shown moderate heritability for major depressive disorder, meaning your genes account for a meaningful share of your risk. But unlike conditions caused by a single gene mutation, depression involves many genes each contributing a small effect. No single “depression gene” has been reliably identified despite enormous studies involving hundreds of thousands of people. What you inherit is more like a general susceptibility, a nervous system that may be more reactive to stress, less efficient at regulating mood, or more prone to inflammation. Whether that susceptibility turns into actual depression depends heavily on what life throws at you.
Stress Hormones and the Brain’s Alarm System
Your body has a built-in stress response system connecting the brain, pituitary gland, and adrenal glands. When you encounter a threat, this system floods your bloodstream with cortisol, the primary stress hormone. In a healthy system, cortisol spikes briefly and then returns to baseline. In depression, this feedback loop often breaks down.
Roughly 40 to 60% of people with major depression show abnormally high cortisol levels or other disruptions in their stress hormone cycle, such as a flattened daily rhythm where cortisol stays elevated instead of dropping at night. This chronic exposure to stress hormones takes a physical toll on the brain. The hippocampus, a region critical for memory and emotional regulation, is especially vulnerable. Studies involving over 600 participants have found that longer cumulative duration of depression, more recurrent episodes, and earlier age of onset are all associated with measurable shrinkage of the hippocampus.
The damage appears to be cumulative. Prolonged cortisol exposure reduces the brain’s ability to grow new neurons and maintain existing connections, particularly by suppressing a key growth factor that keeps brain cells healthy. This helps explain why untreated depression can become harder to recover from over time, as the brain structures needed for emotional resilience gradually weaken.
Beyond the “Chemical Imbalance” Theory
For decades, depression was explained as a simple shortage of serotonin in the brain. This idea became deeply embedded in popular understanding, but a comprehensive 2022 review published in Molecular Psychiatry found no consistent evidence that people with depression have lower serotonin levels or reduced serotonin activity. The two largest genetic studies, involving over 115,000 and 43,000 participants respectively, found no link between the serotonin transporter gene and depression risk.
That doesn’t mean brain chemistry is irrelevant. It means the picture is far more complex than one chemical being too low. Research now points to imbalances between the brain’s excitatory and inhibitory signaling systems. People with depression show altered levels of glutamate (the brain’s main excitatory chemical) and GABA (its main calming chemical) in regions responsible for decision-making, attention, and emotional processing. In the prefrontal cortex, glutamate-related compounds tend to be reduced in depressed patients, and the degree of reduction correlates with how treatment-resistant the depression is. An imbalanced ratio between excitatory and inhibitory signaling, particularly when it develops early in life, appears to create a vulnerability to depressive episodes.
Inflammation as a Driver
One of the more surprising findings in depression research is the role of the immune system. Between 21 and 34% of people with depression show elevated levels of C-reactive protein (CRP), a marker of low-grade inflammation throughout the body. Levels of interleukin-6, an inflammatory signaling molecule, are also consistently elevated in both the blood and spinal fluid of depressed patients.
This isn’t just a coincidence or a side effect of being unwell. Research using data from nearly 145,000 participants in the UK Biobank found a dose-response relationship: the higher the inflammation, the worse the depressive symptoms. Genetic analysis suggests that increased activity along the interleukin-6 pathway may actually be a causal risk factor for depression, not merely a consequence of it. Chronic inflammation can cross into the brain and interfere with the production of mood-regulating chemicals, creating a biological pathway from physical illness, poor diet, or chronic stress directly into depressive symptoms.
Childhood Adversity Leaves Lasting Marks
What happens to you early in life powerfully shapes your risk for depression decades later. Adverse childhood experiences, including abuse, neglect, household dysfunction, and exposure to violence, create a strong, dose-dependent relationship with later depression. In one large study, 19.7% of people with no adverse childhood experiences had scores indicating major depression. Among those with one to three such experiences, that number rose to 29.9%. For those with more than three, it jumped to 62.3%.
The effects persist well beyond childhood. Research consistently shows that exposure to early adversity increases depression risk up to decades after the experiences occurred. The mechanism is partly biological: chronic childhood stress alters the stress hormone system during critical developmental windows, essentially calibrating the brain to expect danger. This leads to a hair-trigger stress response that, over years, produces the same cortisol-driven damage to the hippocampus and mood-regulating circuits seen in chronic adult depression. It also shapes psychological patterns, like difficulty trusting others or a deep sense of worthlessness, that make a person more vulnerable to depressive episodes when facing adult stressors.
Loneliness and Social Disconnection
Humans are wired for social connection, and its absence is a potent risk factor for depression. A systematic review of longitudinal studies found that adults who frequently feel lonely are more than twice as likely to develop depression compared to those who rarely feel lonely. Among children and adolescents, loneliness and social isolation increase the risk of depression and anxiety, with effects lasting up to nine years.
The U.S. Surgeon General’s 2023 advisory on social connection framed the problem in stark terms: the health impact of being socially disconnected is comparable to smoking 15 cigarettes a day and exceeds the risk associated with obesity or physical inactivity. On the flip side, regularly confiding in others is associated with up to 15% lower odds of developing depression, even among people already at higher risk due to past trauma. Social connection isn’t just pleasant. It appears to be genuinely protective at a biological level, helping to buffer the stress hormone and inflammatory pathways that drive depression.
Sleep, Light, and Your Internal Clock
Depression and disrupted sleep are so tightly linked that it can be hard to tell which came first. People with depression typically show a distinct sleep pattern: they enter dream sleep (REM) faster, spend more time in it, and get less of the deep, restorative slow-wave sleep that the brain needs to repair itself. These aren’t just symptoms of feeling bad. They reflect a fundamental misalignment in the body’s internal clock.
Your circadian rhythm, the roughly 24-hour cycle governing sleep, hormone release, and body temperature, is primarily set by light entering your eyes. Specialized cells in the retina detect light and send signals directly to the brain’s master clock, which in turn regulates melatonin production and cortisol timing. When this system falls out of sync, whether from irregular sleep schedules, insufficient daylight, or shift work, mood regulation suffers. One hypothesis suggests that depression involves a phase shift where internal rhythms governing temperature, cortisol, and REM sleep drift out of alignment with the actual sleep-wake cycle. Morning light therapy can correct this shift, and the degree of correction correlates directly with improvement in depressive symptoms.
Gut Bacteria and Mood
Your intestinal bacteria communicate with your brain through neural, hormonal, and immune pathways. The metabolites they produce, particularly short-chain fatty acids created when gut bacteria break down dietary fiber, can cross the blood-brain barrier and directly influence brain function. These compounds affect the production of neurotransmitters, modulate the stress hormone system, and regulate immune responses that are all implicated in depression. A disrupted or impoverished gut microbiome, often the result of a low-fiber diet, antibiotic use, or chronic stress, may remove a key buffer against depressive processes. This is a newer area of research, but it helps explain why diet quality consistently shows up as a risk factor for depression in large population studies.
Medications That Can Trigger Depression
Some commonly prescribed medications list depression as a side effect, which can be easy to overlook when depressive symptoms develop gradually. Corticosteroids, used for conditions like asthma and autoimmune diseases, are well-documented triggers. Certain hormonal treatments carry significant risk: in clinical trials, 22% of patients on one fertility medication and 54% on another developed significant depressive symptoms. Oral contraceptives containing progesterone, some acne medications, and heart medications including certain blood pressure drugs have all been associated with mood changes. If depressive symptoms appear shortly after starting a new medication, that timing is worth noting and discussing with a prescriber.